Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -1.27%272.86M | -14.20%635.04M | -13.84%276.38M | -9.05%740.11M | -13.02%320.78M | -4.51%813.73M | -8.94%368.78M | -11.92%852.15M | 3.33%404.97M | -2.36%967.47M |
| Operating income | -1.27%272.86M | -14.20%635.04M | -13.84%276.38M | -9.05%740.11M | -13.02%320.78M | -4.51%813.73M | -8.94%368.78M | -11.92%852.15M | 3.33%404.97M | -2.36%967.47M |
| Cost of sales | -12.59%-192.46M | 22.97%-367.73M | 28.33%-170.94M | 1.07%-477.42M | -12.41%-238.51M | -6.59%-482.6M | -21.15%-212.18M | -11.25%-452.79M | -19.54%-175.14M | -6.12%-407.01M |
| Operating expenses | -12.59%-192.46M | 22.97%-367.73M | 28.33%-170.94M | 1.07%-477.42M | -12.41%-238.51M | -6.59%-482.6M | -21.15%-212.18M | -11.25%-452.79M | -19.54%-175.14M | -6.12%-407.01M |
| Gross profit | -23.75%80.4M | 1.75%267.31M | 28.15%105.44M | -20.66%262.7M | -47.46%82.28M | -17.09%331.13M | -31.86%156.6M | -28.74%399.37M | -6.34%229.83M | -7.71%560.46M |
| Selling expenses | 3.43%-51.82M | 25.09%-123.23M | 33.29%-53.66M | 13.05%-164.5M | 16.39%-80.44M | 10.12%-189.19M | -13.73%-96.21M | -10.70%-210.49M | 6.09%-84.6M | 26.21%-190.14M |
| Administrative expenses | -5.62%-29.47M | 8.95%-52.03M | -28.72%-27.9M | 11.36%-57.15M | 29.59%-21.68M | 18.19%-64.47M | 30.08%-30.79M | 2.64%-78.81M | 5.45%-44.03M | -19.63%-80.95M |
| Research and development expenses | -21.99%-19.75M | 41.21%-36.67M | 49.71%-16.19M | 4.26%-62.37M | 4.92%-32.19M | 2.38%-65.14M | -2.13%-33.85M | 0.42%-66.73M | -1.45%-33.15M | 13.84%-67.01M |
| Impairment and provision | 176.12%3.46M | -1,082.08%-20.25M | -1,703.89%-4.54M | 89.89%-1.71M | -96.69%283K | 62.33%-16.95M | 127.54%8.54M | 21.10%-44.99M | 23.51%-31.02M | -75.67%-57.02M |
| -Other impairment is provision | 176.12%3.46M | -1,082.08%-20.25M | -1,703.89%-4.54M | 89.89%-1.71M | -96.69%283K | 62.33%-16.95M | 127.54%8.54M | 21.10%-44.99M | 23.51%-31.02M | -75.67%-57.02M |
| Special items of operating profit | 20.46%8.76M | -53.92%10.04M | -30.36%7.27M | 292.01%21.79M | 164.22%10.44M | -123.63%-11.35M | -353.26%-16.25M | 137.54%48.01M | -16.99%6.42M | 108.49%20.21M |
| Operating profit | -180.81%-8.43M | 3,745.92%45.17M | 125.25%10.43M | 92.24%-1.24M | -245.58%-41.3M | -134.42%-15.96M | -127.50%-11.95M | -75.01%46.37M | 0.46%43.46M | 2.28%185.56M |
| Financing income | -47.82%1.16M | -38.18%4.07M | -50.96%2.23M | -49.16%6.59M | -39.53%4.54M | 87.54%12.96M | 37.39%7.5M | -9.15%6.91M | 20.98%5.46M | 6.16%7.61M |
| Financing cost | 79.73%-192K | 85.23%-234K | 30.11%-947K | -26,300.00%-1.58M | -10,323.08%-1.36M | 86.36%-6K | 51.85%-13K | 97.65%-44K | 94.72%-27K | -306.72%-1.88M |
| Earning before tax | -163.71%-7.46M | 1,202.10%49.01M | 130.71%11.71M | 224.97%3.76M | -754.47%-38.12M | -105.66%-3.01M | -109.12%-4.46M | -72.17%53.24M | 3.45%48.89M | 1.87%191.29M |
| Tax | 29.38%-1.11M | 85.23%-5.28M | 37.81%-1.58M | -793.22%-35.71M | 58.90%-2.53M | -188.46%-4M | 18.30%-6.17M | 95.00%-1.39M | 15.22%-7.55M | 16.24%-27.71M |
| After-tax profit from continuing operations | -184.61%-8.57M | 236.90%43.74M | 124.92%10.13M | -355.73%-31.95M | -282.57%-40.65M | -113.52%-7.01M | -125.70%-10.63M | -68.30%51.85M | 7.78%41.34M | 5.75%163.57M |
| Earning after tax | -184.61%-8.57M | 236.90%43.74M | 124.92%10.13M | -355.73%-31.95M | -282.57%-40.65M | -113.52%-7.01M | -125.70%-10.63M | -68.30%51.85M | 7.78%41.34M | 5.75%163.57M |
| Minority profit | ---- | ---- | ---- | 209.27%389K | -519.57%-2.57M | -118.44%-356K | -121.22%-414K | 14.46%1.93M | 83.54%1.95M | 8.42%1.69M |
| Shareholders should account for profits from continuing business | ---- | 235.25%43.74M | ---- | ---32.34M | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | -184.61%-8.57M | 235.25%43.74M | 126.60%10.13M | -385.96%-32.34M | -272.96%-38.09M | -113.33%-6.65M | -125.92%-10.21M | -69.16%49.92M | 5.62%39.39M | 5.72%161.89M |
| Basic earnings per share | -185.39%-0.0076 | 235.44%0.0386 | 126.49%0.0089 | -383.05%-0.0285 | -273.33%-0.0336 | -113.38%-0.0059 | -125.86%-0.009 | -69.23%0.0441 | 5.14%0.0348 | 5.21%0.1433 |
| Diluted earnings per share | -185.39%-0.0076 | 235.44%0.0386 | 126.49%0.0089 | -383.05%-0.0285 | -273.33%-0.0336 | -113.38%-0.0059 | -126.01%-0.009 | -69.23%0.0441 | 4.53%0.0346 | 5.21%0.1433 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.